Harrow Health(IMMY)

5.69 0.00 0.0%

今开:0.0昨收:5.69
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:1.32451678E8

Harrow Health的最新讨论

Imprimis Pharmaceuticals和 Compounding Pharmacy

淘沙见金2017-10-30 11:45

这个制药公司Imprimis Pharmaceuticals $Imprimis Pharmaceuticals, Inc.(IMMY)$ 大涨,原因是因为公司称将会提供比AGN的干眼症治疗药物Restasis更为便宜的替代选择。这个药物第一个月只需要不到1美元,以后每个月花费79美元。对比Restasis每年的花费高达5000美元一年确实便宜不少。听起来很美好...查看全文

Vodka配鱼油救命药2017-10-20 09:45

$Imprimis Pharmaceuticals, Inc.(IMMY)$
IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文

TLS美股研究2017-04-09 21:31

回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 [大笑]查看全文

Harrow Health的公告

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-10 AccNo: 0001493152-17-004968 Size: 3 MB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-05-10 AccNo: 0001493152-17-004958 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2017-05-10 盘后 披露财报,预期EPS -0.19 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-05-02 AccNo: 0001493152-17-004662 Size: 203 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ DEF 14A - Other definitive proxy statements Filed: 2017-04-27 AccNo: 0001493152-17-004479 Size: 958 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-04-19 AccNo: 0001144204-17-021070 Size: 43 KB 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-04-17 AccNo: 0001493152-17-004045 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-04-17 AccNo: 0001493152-17-004007 Size: 150 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-04-06 AccNo: 0001493152-17-003596 Size: 150 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-03-29 AccNo: 0001144204-17-017136 Size: 44 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17